Clinical Trial Update: Treat Primary and Metastatic Liver Tumors

View source ↗

Summary

Clinical trial NCT05240040 sponsored by Methodist Health System has been withdrawn; it concerns the treatment of intrahepatic cholangiocarcinoma and liver tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Methodist Health System | Conditions: Intrahepatic Cholangiocarcinoma, Liver Tumor | Status: WITHDRAWN